Cargando…
Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase
Novel PARP inhibitors with selective mode-of-action have been approved for clinical use. Herein, oxadiazole based ligands that are predicted to target PARP-1 have been synthesized and screened for the loss of cell viability in mammary carcinoma cells, wherein seven compounds were observed to possess...
Autores principales: | Vishwanath, Divakar, Girimanchanaika, Swamy S., Dukanya, Dukanya, Rangappa, Shobith, Yang, Ji-Rui, Pandey, Vijay, Lobie, Peter E., Basappa, Basappa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839658/ https://www.ncbi.nlm.nih.gov/pubmed/35163965 http://dx.doi.org/10.3390/molecules27030703 |
Ejemplares similares
-
Investigation of NPB Analogs That Target Phosphorylation of BAD-Ser99 in Human Mammary Carcinoma Cells
por: Girimanchanaika, Swamy Savvemala, et al.
Publicado: (2021) -
Anti-proliferative activity and characterization data on oxadiazole derivatives
por: Dukanya, et al.
Publicado: (2020) -
Novel 1,3,4-oxadiazole Targets STAT3 Signaling to Induce Antitumor Effect in Lung Cancer
por: Malojirao, Vikas H., et al.
Publicado: (2020) -
Development of 1-(4-(Substituted)piperazin-1-yl)-2-((2-((4-methoxybenzyl)thio)pyrimidin-4-yl)oxy)ethanones That Target Poly (ADP-Ribose) Polymerase in Human Breast Cancer Cells
por: Deveshegowda, Suresha N., et al.
Publicado: (2022) -
New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021)